uk-396,082
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2010 (NCT01091532)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- ThrombinINHIBITOR
F2 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCCn1cnc(C[C@H](CCCN)C(=O)O)c1- Mol. weight
- 239.32 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL398110 ↗
Also known as
- 5-amino-2-((1-n-propyl-1h-imidazol-4-yl)methyl)pentanoic acid
- 5-amino-pimpa
- uk396082
- uk 396082
- uk 396,082
- uk-396082
- uk-396,082
- uk-396,082
- uk-396,082
- uk-396,082
- uk396,082
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01091532 | Phase 1 | Mar 1, 2010 | Pfizer |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 1 | 1 | 1 | 2010 |
1 organizations
Page 1 / 1